Navigation Links
Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
Date:3/4/2008

nt, Vermillion is granted exclusive

rights to the biomarker panel.

Ovarian Cancer Diagnostic Test Progress

-- Received the distinguished Society for Gynecologic Oncologists' (SGO)

Basic Science Poster Award for its abstract, "Prospective independent

validation of a marker panel for distinguishing benign from malignant

pelvic masses." The abstract, which demonstrated that the Company's

Ovarian Tumor Triage Test correctly identified 84 percent of ovarian

cancer cases, compared to only 33 percent identified using standard

diagnosis methods without the test, was presented at the SGO 38th

Annual Meeting on Women's Cancer last year in San Diego.

-- Completed enrollment of 550 patients at 27 medical centers in a

clinical trial to evaluate Vermillion's Ovarian Tumor Triage Test to

differentiate women with ovarian cancer from women with benign pelvic

masses.

-- Presented seven studies at the European Society for Gynecologic

Oncology meeting describing advancements in Vermillion's ovarian cancer

diagnostic program.

-- Data showed that Vermillion's panel of ovarian cancer protein

biomarkers in combination with CA-125 could more accurately identify

early-stage ovarian cancer than could CA-125 alone.

-- Data demonstrated that Vermillion's ovarian cancer biomarker panel

could accurately and with statistical significance predict women with

ovarian cancer who had good prognosis from those who did not. The study

used Kaplan-Meier analysis to show that women with a low panel score

were significantly more likely to survive than women with high scores,

independent of the stage of the disease.

Corporate Developments

-- Renewed a long-standing collaboration with Johns Hopkins University on

the development of novel biomarkers that can be applied towar
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
10. Access Highlighted in Recent BusinessWeek Article
11. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 According to ... Sera, Cryogenic Storage Systems, Thawing Equipment, Alarms), by Biospecimen ... Clinical Trials), End User - Global Forecast to 2020", ... to reach USD 3,731.03 Million by 2020 from USD ... 11.65% between 2015 and 2020. Browse ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... and orthopedic surgeon, Wade McKenna, DO, announced today that the use of sterile, ... resulted in complete healing of an otherwise non-healing surgical knee wound. , The ...
(Date:8/27/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... United Kingdom -based Lab M Holdings, a developer, ... systems. Lab M was founded in ... microbial testing and diagnostic products for the global food, ... sells into more than 70 countries worldwide, and has ...
(Date:8/27/2015)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... 30, 2015. Biorem,s complete second quarter financial statements and MD&A have ... ,000,s except earnings per shareThree-months ended , Six -months endedJune 30 ... 2015 , 2014 Revenue , 4,709 , ... profit , 1,656 , 56 , ...
Breaking Biology Technology:Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4Neogen acquires U.K.-based Lab M Holdings 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3
... Milwaukee, Wis. Personix , a business ... has made a license agreement with Remettra, Inc. ... ,The Arkensas firm's payments system will be integrated with ... electronic versions of paper checks and remittance advices. Payers ...
... Harvey said they work together so well because they know ... The president and CEO of Alliant Energy ... officers must be "joined at the hip" if information technology ... delivering a keynote address Thursday at the Fusion 2006 ...
... Corp. caught IBM 's attention with a government ... allowed residents to conduct business with the city online and ... its annual "Best IBM iSeries On Demand Solution award. The ... to provide more capacity. , ,This year, IBM selected winning ...
Cached Biology Technology:CEOs and CIOs must be 'joined at the hip' 2CEOs and CIOs must be 'joined at the hip' 3
(Date:8/4/2015)... ALBANY, N.Y., Aug. 4, 2015  AMRI (NASDAQ: AMRI ) ... June 30, 2015. Highlights: , Second quarter ... increase from 2014 , Adjusted contract margins of ... EPS of $0.22, including a $0.05 decrease in EPS from royalties ... of $16 million "We are very pleased to ...
(Date:7/31/2015)... , Kina, 31. juli 2015 Den ... bliver afholdt af BGI fra den 22. - 25. oktober ... Konferencen fejrer sin 10-års fødselsdag i år. Siden ... mest indflydelsesrige årlige møder på ,omik,-feltet, og er en ... ICG-10 fokuserer på nylige gennembrud og ...
(Date:7/31/2015)... 2015 A 10 a. Conferência Internacional ... BGI de 22-25 de outubro de 2015, em ... está celebrando seu 10 o. aniversário este ano. Desde ... das reuniões mais influentes do mundo no ramo das ... e prazerosos. A ICG-10 se concentra ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... Mass. -- Public health crises of the past decade ... countries and caused about 1,000 deaths, and the 2009 H1N1 ... heightened awareness that new viruses or bacteria could spread quickly ... epidemiologists and scientists who study complex network systems such ...
... Scientists at Joslin Diabetes Center have identified biological mechanisms ... against kidney disease, and also mechanisms that inhibit its ... online by Diabetes, may lead to the development of ... to prevent the harmful effects of hyperglycemia on renal ...
... sharks recorded in Britain,s seas could be increasing, decades ... 20th century. The most comprehensive analysis ever undertaken of ... of Exeter, the Marine Conservation Society (MCS), Cornwall Wildlife ... the journal Marine Ecology Progress Series . ...
Cached Biology News:New model of disease contagion ranks US airports in terms of their spreading influence 2New model of disease contagion ranks US airports in terms of their spreading influence 3Joslin researchers gain new understanding of diabetes and kidney disease 2Joslin researchers gain new understanding of diabetes and kidney disease 3Public sightings suggest increase in basking sharks in British waters 2Public sightings suggest increase in basking sharks in British waters 3
... clear, APET plastic tray. Ideal for staining ... trays used for multipurposes. Pour spouts in ... marker or label may be used for ... on rockers or shakers for staining several ...
ID clarifier: non-treated with lid...
... fast and reliable scalable automation for today's drug discovery ... are available in three base configurations; Mini Workstation Series, ... ... All Staccato Application Series systems use a ...
... Systems provide fast and reliable automation ... and drug development laboratories. Staccato Custom ... specifications, providing solutions that are tailored ... Custom Systems are controlled with either ...
Biology Products: